In Depth

High-value oncology deals drive China’s drug licensing boom

AI takes charge of data, but challenges linger

In a Honduran city, biotechs create gene therapy cocktails to fight aging

APAC’s rising stars beyond China

ASH 2025: AbbVie and Genmab’s Epkinly sets new standard in second-line FL